General Information
Revision date
2013-05-02
Product name
Levonorgestrel Assay Standard
CAS No.
797-63-7
1.2.1 Relevant identified uses
Reference material for laboratory use only
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
+44 (0) 20 3080 6561 (Monday - Friday 8am - 5pm
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360, H362
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
CLP CLASSIFICATION
GHS08 health hazard Carc. 2 H351 Suspected of causing cancer. Repr. 1A H360-H362 May damage fertility or the unborn child. May cause harm to breast-fed children.
EU Classification
Directive 67/548/EEC or Directive 1999/45/EC T; Toxic R60-61: May impair fertility. May cause harm to the unborn child. Xn; Harmful R40: Limited evidence of a carcinogenic effect. R64: May cause harm to breastfed babies. · Information concerning particular hazards for human and environment: Not applicable.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The substance is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. H360-H362 May damage fertility or the unborn child. May cause harm to breast-fed children.
Precautionary statements
P263 Avoid contact during pregnancy/while nursing. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P281 Use personal protective equipment as required. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
Restricted to professional users.
PBT Substances
Not applicable
vPvB Substances
Not applicable
